B. Roche

发表

The Cold European Winter of 2005–2006 Assisted the Spread and Persistence of H5N1 Influenza Virus in Wild Birds

M. Gilbert, J. Pinto, T. Robinson, 2010, EcoHealth.

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France

P. Marcellin, X. Causse, F. Zoulim, 2016, Digestive Diseases and Sciences.

Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B

D. Samuel, B. Roche, 2004 .

Evolving strategies to prevent HBV recurrence

D. Samuel, B. Roche, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Management of HCV Infection After Liver Transplantation

D. Samuel, B. Roche, A. Coilly, 2019, Evidence-based Gastroenterology and Hepatology 4e.

Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance

D. Samuel, B. Roche, A. Coilly, 2015, Viruses.

Are viral or host factors predictive of response to interferon-ribavirin in transplant patients with hepatitis C?

D. Samuel, B. Roche, 2010, Journal of hepatology.

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

J. Albrecht, D. Samuel, H. Bismuth, 2003, Gastroenterology.

HBV DNA persistence 10 years after liver transplantation despite successful anti‐HBS passive immunoprophylaxis

D. Samuel, H. Bismuth, C. Féray, 2003, Hepatology.

SENTINEL L YMPH NODE INVOLVEMENT AND A HIGH BRESLOW INDEX ARE INDEPENDENT FACTORS OF RISK FOR EARL Y RELAPSE OF MELANOMA

Braun, D., R., 2014 .

Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors

D. Samuel, J. Emile, C. Féray, 2002, Gut.

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France

H. Ramroth, T. Asselah, D. Thabut, 2020, Digestive Diseases and Sciences.

Optimal Management of HCV Transplant Patients

D. Samuel, B. Roche, A. Coilly, 2014, Current Hepatology Reports.

Risk factors for hepatitis C recurrence after liver transplantation

D. Samuel, B. Roche, 2007, Journal of viral hepatitis.

Optimum timing of treatment for hepatitis C infection relative to liver transplantation.

D. Samuel, B. Roche, A. Coilly, 2016, The lancet. Gastroenterology & hepatology.

[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience].

D. Samuel, H. Bismuth, C. Féray, 2001, Gastroentérologie Clinique et Biologique.

Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis

S. Dorman, M. Reichler, T. Sterling, 2018, The Journal of infectious diseases.

Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: a French experience on 250 patients over 15 years (the Orfèvre study).

D. Samuel, J. Dumortier, O. Guillaud, 2014, Clinics and research in hepatology and gastroenterology.

Universal hepatitis B virus screening in patients receiving immunosuppressive therapy: a small step for the oncologists, a major advance for prevention of hepatitis B virus reactivation.

D. Samuel, B. Roche, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients.

D. Samuel, E. Ballot, F. Saliba, 2012, Journal of hepatology.

Fetal congenital heart block and maternal systemic lupus erythematosus: Can plasma exchanges play a useful role?

O. Meyer, B. Roche, L. Guillevin, 1992 .

Current management and perspectives for HCV recurrence after liver transplantation

D. Samuel, B. Roche, A. Coilly, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study

L. Rostaing, E. Thervet, A. Loupy, 2016, Transplantation.

News and challenges in the treatment of hepatitis C in liver transplantation

D. Samuel, B. Roche, A. Coilly, 2016, Liver international (Print).

Prevention of Hepatitis B Virus Reinfection in Liver Transplant Recipients

D. Samuel, B. Roche, 2014, Intervirology.

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?

V. de Lédinghen, D. Samuel, J. Dumortier, 2015, PloS one.

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis Delta.

F. Roudot-thoraval, F. Zoulim, D. Roulot, 2020, Journal of hepatology.

Predictive value of TNF-α, IFN-γ, and IL-10 for tuberculosis among recently exposed contacts in the United States and Canada

S. Dorman, M. Reichler, T. Sterling, 2020, BMC Infectious Diseases.

Liver–kidney recipients with chronic viral hepatitis C treated with interferon‐alpha

D. Samuel, B. Roche, B. Charpentier, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis

V. de Lédinghen, D. Thabut, R. Moreau, 2007, Hepatology.

Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis

D. Samuel, F. Saliba, B. Roche, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin

F. Nevens, D. Samuel, B. Roche, 2015, Transplantation.

Treatment of patients with HBV-related decompensated cirrhosis and liver transplanted patients.

D. Samuel, B. Roche, 2013, Clinics in liver disease.

Chapter 9 – Transplantation for Hepatitis A and B

D. Samuel, B. Roche, 2013 .

Liver transplantation in viral hepatitis: prevention of recurrence.

D. Samuel, B. Roche, 2008, Best practice & research. Clinical gastroenterology.

Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective

D. Samuel, N. Terrault, B. Roche, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B

D. Samuel, B. Roche, 2004, Transplant international : official journal of the European Society for Organ Transplantation.

8 – Transplantation for Viral Hepatitis A and B

D. Samuel, B. Roche, 2005 .

Transplantation and prevention of reinfection

D. Samuel, B. Roche, 2004 .

Hepatitis C virus infection and allogeneic bone marrow transplantation.

B. Roche, C. Cordonnier, M. Kuentz, 1994, Transplantation.

De novo and apparent de novo hepatitis B virus infection after liver transplantation.

D. Samuel, H. Bismuth, C. Féray, 1997, Journal of hepatology.

Hepatitis B Recurrence: Major Milestones and Current Status

D. Samuel, B. Roche, 2016 .

Prevention of Post-transplant HBV

D. Samuel, B. Roche, 2015, Current Hepatology Reports.

Hepatitis C virus treatment pre‐ and post‐liver transplantation

D. Samuel, B. Roche, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Significance of isolated hepatic veno‐occlusive disease/sinusoidal obstruction syndrome after liver transplantation

D. Samuel, F. Saliba, L. Bonhomme-Faivre, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Treatment of Hepatitis C in Liver Transplant Patients

D. Samuel, B. Roche, 2004 .

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

J. Izopet, D. Roulot, P. Colson, 2009, Journal of medical virology.

Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C

D. Samuel, B. Roche, 2004 .

Risk of liver retransplantation for viral hepatitis

D. Samuel, H. Bismuth, C. Féray, 1997 .

Nodular Regenerative Hyperplasia Is Not a Rare Condition After Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival

D. Samuel, C. Féray, E. Vibert, 2022, Transplantation.

Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen

D. Samuel, C. Féray, B. Roche, 2001, Journal of medical virology.

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.

D. Samuel, J. Dumortier, O. Guillaud, 2014, Journal of hepatology.

Cadaveric full-size liver transplantation and the graft alternatives in adults: a comparative study from a single centre.

D. Samuel, B. Falissard, B. Roche, 2006, Journal of hepatology.

Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).

P. Bedossa, F. Degos, B. Roche, 2010, Journal of hepatology.

Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation.

D. Samuel, H. Bismuth, P. Majno, 1999, Journal of hepatology.

Retransplantation of the liver for recurrent hepatitis B virus infection: the Paul Brousse experience.

D. Samuel, H. Bismuth, P. Majno, 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Liver transplantation for hepatitis B virus-related liver disease: indications, prevention of recurrence and results.

D. Samuel, B. Roche, 2003, Journal of hepatology.

Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen–positive liver grafts receiving hepatitis B immunoglobulins

D. Samuel, B. Roche, A. Roque-Afonso, 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.

D. Samuel, C. Bréchot, Guillaume Fallot, 2008, Gastroenterology.

Liver Transplantation in Delta Virus Infection

D. Samuel, B. Roche, 2012, Seminars in Liver Disease.

Hepatitis: Viral load predicts HBV recurrence after liver transplant

D. Samuel, B. Roche, 2010, Nature Reviews Gastroenterology &Hepatology.

Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study

D. Samuel, G. Ercolani, G. Tisone, 2016, Transplantation.

Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study

F. Zoulim, D. Samuel, A. Bauhofer, 2022, Annals of transplantation.

Management of post transplant hepatitis C in the direct antiviral agents era

D. Samuel, B. Roche, A. Coilly, 2015, Hepatology International.

Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity

D. Samuel, B. Roche, F. Medja, 2009, AIDS.

CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Hepatocellular Carcinoma Is Associated With an Increased Risk of Hepatitis B Virus Recurrence After Liver Transplantation

D. Samuel, C. Bréchot, Guillaume Fallot, 2008 .

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

D. Samuel, H. Bismuth, C. Féray, 2007, Hepatology.

Management of Hepatitis B Virus Infection Post Transplantation

D. Samuel, B. Roche, 2021 .

Aspects of hepatitis C virus infection relating to liver transplantation

D. Samuel, B. Roche, 2006, European journal of gastroenterology & hepatology.

Withdrawal of posttransplant hepatitis B virus prophylaxis: A blind test

D. Samuel, B. Roche, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Management of Hepatitis B Virus Infection Pre Transplantation

D. Samuel, B. Roche, 2021 .

Fibrosing Cholestatic Hepatitis in HIV/HCV Co‐Infected Transplant Patients—Usefulness of Early Markers After Liver Transplantation

D. Samuel, B. Roche, A. Coilly, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

531 TENOFOVIR DF TREATMENT IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH BASELINE DECREASED GLOMERULAR FILTRATION RATE

P. Marcellin, X. Causse, F. Zoulim, 2012 .

Antiviral therapy in HCV-infected cirrhotics awaiting liver transplantation: A costly strategy for mixed virological results.

D. Samuel, B. Roche, 2009, Journal of hepatology.

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.

D. Samuel, C. Robert, O. Lambotte, 2018, Journal of hepatology.

The Histologic Pattern of “Biliary Tract Pathology” Is Accurate for the Diagnosis of Biliary Complications

D. Samuel, B. Falissard, B. Roche, 2005, The American journal of surgical pathology.

Transplantation hépatique de l'adulte à partir de donneur vivant

D. Samuel, H. Bismuth, C. Féray, 2008 .

Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.

D. Samuel, J. Dumortier, F. Durand, 2016, World journal of gastroenterology.

Risk factors for new‐onset diabetes mellitus following liver transplantation and impact of hepatitis c infection : An observational multicenter study

J. Dumortier, C. Duvoux, F. Saliba, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods

R. Braun, D. Slosman, A. Kurt, 2003, Melanoma research.

The impact of treatment of hepatitis C with DAAs on the occurrence of HCC

D. Samuel, B. Roche, A. Coilly, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Idiopathic Post Liver-Transplant Hepatitis Remains Obscure with Respect to Its Etiology and Relationship with Immunosuppressiona

D. Samuel, E. Ballot, F. Saliba, 2015 .

Practical Management of Boceprevir and Immunosuppressive Therapy in Liver Transplant Recipients with Hepatitis C Virus Recurrence

D. Samuel, B. Roche, A. Coilly, 2012, Antimicrobial Agents and Chemotherapy.

Liver injury from cancer immunotherapy using monoclonal immune checkpoint inhibitors

D. Samuel, C. Robert, O. Lambotte, 2018 .

Sentinel lymph node involvement and a high Breslow index are independent factors of risk for early relapse of melanoma

R. Braun, F. Buchegger, B. Roche, 2007, Nuklearmedizin.

Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma.

J. Bourhis, S. Koscielny, T. Soussi, 1996, Journal of the National Cancer Institute.

Fulminant hepatitis after grand mal seizures: Mechanisms and role of liver transplantation

B. Fromenty, D. Samuel, F. Saliba, 2003, Hepatology.

Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals

D. Samuel, B. Roche, A. Coilly, 2015, Liver international : official journal of the International Association for the Study of the Liver.

The value of early transjugular liver biopsy after liver transplantation.

H. Bismuth, B. Roche, D. Azoulay, 1996, Transplantation.

The difficulties of managing severe hepatitis B virus reactivation

D. Samuel, B. Roche, 2011, Liver international : official journal of the International Association for the Study of the Liver.

All liver recipients benefit from the protocol 10‐year liver biopsies

D. Samuel, H. Bismuth, B. Falissard, 2003, Hepatology.

Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis

F. Zoulim, D. Samuel, M. Levrero, 2023, JHEP reports : innovation in hepatology.

Combined prophylaxis might still be better than monoprophylaxis with entecavir following liver transplantation for hepatitis B.

D. Samuel, B. Roche, 2012, Gastroenterology.

Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: Reliability of the 1999 Banff schema

D. Samuel, H. Bismuth, B. Falissard, 2002, Hepatology.

Management of Transplant Patients Infected with HCV

D. Samuel, B. Roche, A. Coilly, 2021 .

Management of HCV transplant patients with triple therapy

D. Samuel, B. Roche, A. Coilly, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Immunoproteomic Analysis of Potentially Severe Non‐Graft‐Versus‐Host Disease Hepatitis After Allogenic Bone Marrow Transplantation

J. L. Le Caer, D. Samuel, E. Ballot, 2013, Hepatology.

[Pneumocystis carinii and cytomegalovirus pneumonia after corticosteroid therapy in acute severe alcoholic hepatitis: 2 case reports].

D. Samuel, H. Bismuth, C. Féray, 2002, Gastroenterologie clinique et biologique.

Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.

D. Samuel, H. Bismuth, C. Féray, 2005, Journal of hepatology.

Long‐term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation

D. Samuel, F. Saliba, B. Roche, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT).

D. Samuel, F. Durand, M. Carrieri, 2017, Clinics and research in hepatology and gastroenterology.

Hepatitis E infection in patients with severe acute alcoholic hepatitis

D. Samuel, F. Saliba, B. Roche, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Paul Brousse Liver Transplantation: the first 1,500 cases.

D. Samuel, H. Bismuth, C. Féray, 2000, Clinical transplants.

Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: Role of an aggressive approach

D. Samuel, M. L. de la Mata, B. Roche, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Leiomyosarcoma of the pulmonary hilar vessels.

A. Kurt, B. Roche, A. Spiliopoulos, 1992, The Thoracic and cardiovascular surgeon.

Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C

D. Samuel, B. Roche, 2005, Transplant International.

Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: difficult to manage but essential for success.

D. Samuel, B. Roche, 2007, Journal of hepatology.

Hepatitis C virus: Up to the minute

D. Samuel, B. Roche, 2010 .

Treatment with Bulevirtide in patients with chronic HBV/HDV co-infection. Safety and efficacy at month 18 in real-world settings

V. de Lédinghen, T. Asselah, X. Causse, 2022, Journal of Hepatology.

Is early antiviral therapy for recurrent hepatitis C after liver transplantation superior to later treatment? The answer is no

D. Samuel, B. Roche, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Adefovir therapy for HBV infection after liver transplantation (LT)

D. Samuel, H. Bismuth, C. Féray, 2002 .

47 EFFICACY AND SAFETY OF PROTEASE INHIBITORS FOR SEVERE HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A FIRST MULTICENTRIC EXPERIENCE

D. Samuel, B. Roche, A. Coilly, 2012 .

13 Liver transplantation of HIV-HCV and HIV-HBV coinfected patients: A large experience in a single centre

D. Samuel, H. Bismuth, C. Féray, 2006 .

124 HCV viral recurrence and liver mitochondrial damage after liver transplantation (LT) in HIV-HCV coinfected patients

D. Samuel, C. Féray, F. Saliba, 2004 .

Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes.

A. Becq, D. Samuel, B. Roche, 2013, Transplantation.

1422 END OF TREATMENT RESPONSE AFTER PROTEASE INHIBITOR (PI)- BASED THERAPY FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC EUROPEAN EXPERIENCE

D. Samuel, J. Dumortier, F. Durand, 2013 .